A Toll-like receptor 2 ligand, Pam3CSK4, augments interferon-γ-induced nitric oxide production via a physical association between MyD88 and interferon-γ receptor in vascular endothelial cells

Immunology

Volumn 140, Issue 3, 2013, Pages 352-361

  Tsolmongyn, Bilegtsaikhan ^a   Koide, Naoki ^a   Jambalganiin, Ulziisaikhan ^a   Odkhuu, Erdenezaya ^a   Naiki, Yoshikazu ^a   Komatsu, Takayuki ^a   Yoshida, Tomoaki ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interferon receptor; MyD88; Pam3CSK4; Toll like receptor 2; Vascular endothelial cells

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; JANUS KINASE 1; JANUS KINASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MYELOID DIFFERENTIATION FACTOR 88; N PALMITOYL [2,3 BIS(PALMITOYLOXY)PROPYL]CYSTEINYLSERYLLYSYLLYSYLLYSYLLYSINE; NITRIC OXIDE; SERINE; STAT1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

INTERFERON-Γ RECEPTOR; MYD88; PAM3CSK4; TOLL-LIKE RECEPTOR 2; VASCULAR ENDOTHELIAL CELLS;

ANIMALS; CELL LINE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERFERON-STIMULATED GENE FACTOR 3; LIPOPEPTIDES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, INTERFERON; TOLL-LIKE RECEPTOR 2;

EID: 84884938860     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12147     Document Type: Article

References (22)

1. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7:803-15.
2. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84.
3. Sikorski K, Czerwoniec A, Bujnicki JM, Wesoly J, Bluyssen HA. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease. Cytokine Growth Factor Rev 2011; 22:211-9.
4. Schroder K, Sweet MJ, Hume DA. Signal integration between IFNγ and TLR signaling pathways in macrophages. Immunobiology 2006; 211:511-24.
5. Kovarik P, Stoiber D, Novy M, Decker T. Stat1 combines signals derived from IFN-γ and LPS receptors during macrophage activation. EMBO J 1998; 17:3660-8.
6. Dalpke AH, Eckerle S, Frey M, Heeg K. Triggering of Toll-like receptors modulates IFN-γ signaling: involvement of serine 727 STAT1 phosphorylation and suppressors of cytokine signaling. Eur J Immunol 2003; 33:1776-87.
7. Schroder K, Spille M, Pilz A et al. Differential effects of CpG DNA on IFN-β induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages. J Immunol 2007; 179:3495-503.
8. Liljeroos M, Vuolteenaho R, Rounioja S, Henriques-Normark B, Hallman M, Ojaniemi M. Bacterial ligand of TLR2 signals Stat activation via induction of IRF1/2 and interferon-α production. Cell Signal 2008; 20:1873-81.
9. Morikawa A, Koide N, Kato Y, Sugiyama T, Chakravortty D, Yoshida T, Yokochi T. Augmentation of nitric oxide production by γ interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor α and lipopolysaccharide. Infect Immun 2000; 68:6209-14.
10. Koide N, Mu MM, Hassan F et al. Lipopolysaccharide enhances interferon-γ-induced nitric oxide (NO) production in murine vascular endothelial cells via augmentation of interferon regulatory factor-1 activation. J Endotoxin Res 2007; 13:167-75.
11. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-8.
12. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
13. Dagvadorj J, Naiki Y, Tumurkhuu G, Noman AS, Iftakhar-E-Khuda I, Komatsu T, Yoshida T, Yokochi T. Tumor necrosis factor-α augments lipopolysaccharide-induced suppressor of cytokine signaling 3 (SOCS-3) protein expression by preventing the degradation. Immunology 2010; 129:97-104.
14. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat Rev Immunol 2007; 7:353-64.
15. Ksienzyk A, Neumann B, Kröger A. IRF-1 is critical for IFNγ mediated immune surveillance. Oncoimmunology 2012; 1:533-4.
16. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89.
17. Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases. Immunity 2009; 31:539-50.
18. Takauji R, Iho S, Takatsuka H et al. CpG-DNA-induced IFN-α production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J Leukoc Biol 2002; 72:1011-9.
19. Rhee SH, Jones BW, Toshchakov V, Vogel SN, Fenton MJ. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J Biol Chem 2003; 278:22506-12.
20. Sun D, Ding A. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA. Nat Immunol 2006; 7:375-81.
21. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82:241-50.
22. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, Müller M, Decker T. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-γ-dependent innate immunity. Immunity 2003; 19:793-802.